Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7861274, 10 pages
http://dx.doi.org/10.1155/2016/7861274
Research Article

Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer

1Department of Gastroenterology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China
2School of Life Sciences, Shanghai University, Shanghai 200444, China
3Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China

Received 31 May 2016; Revised 18 July 2016; Accepted 7 September 2016

Academic Editor: Yungang Xu

Copyright © 2016 Hang Yin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Hidalgo, S. Cascinu, J. Kleeff et al., “Addressing the challenges of pancreatic cancer: future directions for improving outcomes,” Pancreatology, vol. 15, no. 1, pp. 8–18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Verbeke, M. Löhr, J. S. Karlsson, and M. Del Chiaro, “Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties,” Cancer Treatment Reviews, vol. 41, no. 1, pp. 17–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. D. Logsdon and W. Lu, “The significance of ras activity in pancreatic cancer initiation,” International Journal of Biological Sciences, vol. 12, no. 3, pp. 338–346, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Mihaljevic, C. W. Michalski, H. Friess, and J. Kleeff, “Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis,” Langenbeck's Archives of Surgery, vol. 395, no. 4, pp. 295–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Schweiger, M. Kerick, B. Timmermann, and M. Isau, “The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations,” Cancer and Metastasis Reviews, vol. 30, no. 2, pp. 199–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. A. Sohn, G. H. Su, B. Ryu, C. J. Yeo, and S. E. Kern, “High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells,” Annals of Surgery, vol. 233, no. 5, pp. 696–703, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Guo, H. Wei, J. Hu, S. Sun, J. Long, and X. Wang, “U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model,” Oncology Reports, vol. 34, no. 2, pp. 699–706, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Q. Tao, X. P. Zhou, C. Z. Liang et al., “TGF-β 3 and IGF-1 synergy ameliorates nucleus pulposus mesenchymal stem cell differentiation towards the nucleus pulposus cell type through MAPK/ERK signaling,” Growth Factors, vol. 33, no. 5-6, pp. 326–336, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Zheng, G. Jiang, H. Mei et al., “Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells,” BMC Cancer, vol. 10, article 33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Krühn, A. Wang, J. H. Fruehauf, and H. Lage, “Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cells,” Cell Cycle, vol. 8, no. 20, pp. 3349–3354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Lunardi, R. J. Muschel, and T. B. Brunner, “The stromal compartments in pancreatic cancer: are there any therapeutic targets?” Cancer Letters, vol. 343, no. 2, pp. 147–155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. R. M. Perera and N. Bardeesy, “Pancreatic cancer metabolism: breaking it down to build it back up,” Cancer Discovery, vol. 5, no. 12, pp. 1247–1261, 2015. View at Publisher · View at Google Scholar
  13. A. Grimont, A. V. Pinho, M. J. Cowley et al., “SOX9 regulates ERBB signalling in pancreatic cancer development,” Gut, vol. 64, no. 11, pp. 1790–1799, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Javle, Y. Li, D. Tan et al., “Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer,” PLoS ONE, vol. 9, no. 1, Article ID e85942, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-C. Tang and Y.-C. Chen, “Novel therapeutic targets for pancreatic cancer,” World Journal of Gastroenterology, vol. 20, no. 31, pp. 10825–10844, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Vassaux, A. Angelova, P. Baril, P. Midoux, J. Rommelaere, and P. Cordelier, “The promise of gene therapy for pancreatic cancer,” Human Gene Therapy, vol. 27, no. 2, pp. 127–133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-X. Liu, Z.-S. Xia, and Y.-Q. Zhong, “Gene therapy in pancreatic cancer,” World Journal of Gastroenterology, vol. 20, no. 37, pp. 13343–13368, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Brais, S. E. Davies, M. O'Donovan et al., “Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials,” Pancreatology, vol. 12, no. 1, pp. 8–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Yeo, H. He, G. S. Baldwin, and M. Nikfarjam, “The role of p21-activated kinases in pancreatic cancer,” Pancreas, vol. 44, no. 3, pp. 363–369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. E. K. Colvin and C. J. Scarlett, “A historical perspective of pancreatic cancer mouse models,” Seminars in Cell and Developmental Biology, vol. 27, pp. 96–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Yuan, Y.-H. Zhang, S. Wan, S. Wang, and X.-Y. Kong, “Mining for candidate genes related to pancreatic cancer using protein-protein interactions and a shortest path approach,” BioMed Research International, vol. 2015, Article ID 623121, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kanehisa, Y. Sato, M. Kawashima, M. Furumichi, and M. Tanabe, “KEGG as a reference resource for gene and protein annotation,” Nucleic Acids Research, vol. 44, no. 1, pp. D457–D462, 2016. View at Publisher · View at Google Scholar
  23. M. A. Harris, J. I. Deegan, J. Lomax et al., “The gene ontology project in 2008,” Nucleic Acids Research, vol. 36, pp. D440–D444, 2008. View at Google Scholar
  24. H. Peng, F. Long, and C. Ding, “Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy,” IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. 27, no. 8, pp. 1226–1238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Ogata, S. Goto, K. Sato, W. Fujibuchi, H. Bono, and M. Kanehisa, “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 27, no. 1, pp. 29–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Franceschini, D. Szklarczyk, S. Frankild et al., “STRING v9.1: protein-protein interaction networks, with increased coverage and integration,” Nucleic Acids Research, vol. 41, no. 1, pp. D808–D815, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Carmona-Saez, M. Chagoyen, F. Tirado, J. M. Carazo, and A. Pascual-Montano, “GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists,” Genome Biology, vol. 8, no. 1, article R3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Huang, L. Chen, Y.-D. Cai, and K.-C. Chou, “Classification and analysis of regulatory pathways using graph property, biochemical and physicochemical property, and functional property,” PLoS ONE, vol. 6, no. 9, Article ID e25297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Huang, J. Zhang, Z.-P. Xu et al., “Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches,” Biochimie, vol. 94, no. 4, pp. 1017–1025, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Yang, L. Chen, X. Kong, T. Huang, and Y.-D. Cai, “Analysis of tumor suppressor genes based on gene ontology and the KEGG pathway,” PLoS ONE, vol. 9, no. 9, Article ID e107202, 2014. View at Publisher · View at Google Scholar
  31. L. Chen, Y. Zhang, M. Zheng, T. Huang, and Y. Cai, “Identification of compound–protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds,” Molecular Genetics and Genomics, vol. 291, no. 6, pp. 2065–2079, 2016. View at Publisher · View at Google Scholar
  32. L. Chen, C. Chu, and K. Feng, “Predicting the types of metabolic pathway of compounds using molecular fragments and sequential minimal optimization,” Combinatorial Chemistry & High Throughput Screening, vol. 19, no. 2, pp. 136–143, 2016. View at Publisher · View at Google Scholar
  33. Y. Zhang, C. Ding, and T. Li, “Gene selection algorithm by combining reliefF and mRMR,” BMC Genomics, vol. 9, no. 2, article S27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Liu, L. Chen, Y.-H. Zhang et al., “Analysis and prediction of drug-drug interaction by minimum redundancy maximum relevance and incremental feature selection,” Journal of Biomolecular Structure and Dynamics, 2016. View at Publisher · View at Google Scholar
  35. Z. Li, X. Zhou, Z. Dai, and X. Zou, “Classification of G-protein coupled receptors based on support vector machine with maximum relevance minimum redundancy and genetic algorithm,” BMC Bioinformatics, vol. 11, article 325, 2010. View at Google Scholar
  36. H. Mohabatkar, M. Mohammad Beigi, and A. Esmaeili, “Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine,” Journal of Theoretical Biology, vol. 281, no. 1, pp. 18–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Chen, Y. Zhang, T. Huang, and Y. Cai, “Gene expression profiling gut microbiota in different races of humans,” Scientific Reports, vol. 6, article 23075, 2016. View at Publisher · View at Google Scholar
  38. Z. Liu, J. Han, H. Lv, J. Liu, and R. Liu, “Computational identification of circular RNAs based on conformational and thermodynamic properties in the flanking introns,” Computational Biology and Chemistry, vol. 61, pp. 221–225, 2016. View at Publisher · View at Google Scholar
  39. L. Chen, C. Chu, J. Lu, X. Kong, T. Huang, and Y.-D. Cai, “Gene ontology and KEGG pathway enrichment analysis of a drug target-based classification system,” PLoS ONE, vol. 10, no. 5, Article ID e0126492, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. S. A. Korkmaz, M. F. Korkmaz, M. Poyraz, and F. Yakuphanoglu, “Diagnosis of breast cancer nano-biomechanics images taken from atomic force microscope,” Journal of Nanoelectronics and Optoelectronics, vol. 11, no. 4, pp. 551–559, 2016. View at Publisher · View at Google Scholar
  41. L. Chen, C. Chu, T. Huang, X. Kong, and Y.-D. Cai, “Prediction and analysis of cell-penetrating peptides using pseudo-amino acid composition and random forest models,” Amino Acids, vol. 47, no. 7, pp. 1485–1493, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Huang, M. Wang, and Y.-D. Cai, “Analysis of the preferences for splice codes across tissues,” Protein and Cell, vol. 6, no. 12, pp. 904–907, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Wang, Y. Zhang, J. Lu, W. Cui, J. Hu, and Y. Cai, “Analysis and identification of aptamer-compound interactions with a maximum relevance minimum redundancy and nearest neighbor algorithm,” BioMed Research International, vol. 2016, Article ID 8351204, 9 pages, 2016. View at Publisher · View at Google Scholar
  44. T. Huang, Y. Shu, and Y.-D. Cai, “Genetic differences among ethnic groups,” BMC Genomics, vol. 16, article 1093, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Chen, C. Chu, Y.-H. Zhang et al., “Analysis of gene expression profiles in the human brain stem, cerebellum and cerebral cortex,” PLoS ONE, vol. 11, no. 7, Article ID e0159395, 2016. View at Publisher · View at Google Scholar
  46. J. Han, F. Wang, S.-Q. Yuan et al., “Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancer,” BMC Cancer, vol. 14, no. 1, article 650, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Bai, X. Zhi, Q. Zhang et al., “Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis,” Cancer Letters, vol. 355, no. 2, pp. 281–287, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. N. P. Zimmerman, I. Roy, A. D. Hauser, J. M. Wilson, C. L. Williams, and M. B. Dwinell, “Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells,” Molecular Carcinogenesis, vol. 54, no. 3, pp. 203–215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Kang, W. Hou, Q. Zhang et al., “RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer,” Cell Death and Disease, vol. 5, no. 10, Article ID e1480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. Q. Wang, Q. Ni, X. Wang, H. Zhu, Z. Wang, and J. Huang, “High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival,” Medical Oncology, vol. 32, no. 1, p. 372, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Black, P. F. Pinsky, R. L. Grubb et al., “Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 11, pp. 2374–2382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. D.-S. Ming, S. Pham, S. Deb et al., “Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 143, pp. 19–28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. E. J. Duell, N. Travier, L. Lujan-Barroso et al., “Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort,” International Journal of Cancer, vol. 132, no. 9, pp. 2164–2175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Zhou and Y. Du, “Acquisition of resistance of pancreatic cancer cells to 2-methoxyestradiol is associated with the upregulation of manganese superoxide dismutase,” Molecular Cancer Research, vol. 10, no. 6, pp. 768–777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. J. A. Pierzynski, M. A. Hildebrandt, A. M. Kamat et al., “Genetic variants in the Wnt/β-catenin signaling pathway as indicators of bladder cancer risk,” The Journal of Urology, vol. 194, no. 6, pp. 1771–1776, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Yoshida, T. Kinugasa, K. Ohshima et al., “Analysis of Wnt and β-catenin expression in advanced colorectal cancer,” Anticancer Research, vol. 35, no. 8, pp. 4403–4410, 2015. View at Google Scholar · View at Scopus
  57. M. Ilmer, A. R. Boiles, I. Regel et al., “RSPO2 enhances canonical wnt signaling to confer stemness-associated traits to susceptible pancreatic cancer cells,” Cancer Research, vol. 75, no. 9, pp. 1883–1896, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. I. Wall and I. G. H. Schmidt-Wolf, “Effect of Wnt inhibitors in pancreatic cancer,” Anticancer Research, vol. 34, no. 10, pp. 5375–5380, 2014. View at Google Scholar · View at Scopus
  59. Y. Zhao, Y. Yang, J. Trovik et al., “A novel Wnt regulatory axis in endometrioid endometrial cancer,” Cancer Research, vol. 74, no. 18, pp. 5103–5117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Han, Y. Luo, Y. Wang, Y. Chen, M. Li, and Y. Jiang, “Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and ZEB-1 signaling pathway,” Oncology Letters, vol. 11, no. 1, pp. 753–759, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Beuran, I. Negoi, S. Paun et al., “The epithelial to mesenchymal transition in pancreatic cancer: a systematic review,” Pancreatology, vol. 15, no. 3, pp. 217–225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Zhou, A. M. Jubb, K. Lyle et al., “PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition,” The Journal of Pathology, vol. 234, no. 4, pp. 502–513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Quimbaya, E. Raspé, G. Denecker et al., “Deregulation of the replisome factor MCMBP prompts oncogenesis in colorectal carcinomas through chromosomal instability,” Neoplasia, vol. 16, no. 9, pp. 694–709, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Matsuda, T. Ishiwata, N. Izumiyama-Shimomura et al., “Gradual telomere shortening and increasing chromosomal instability among PanIN grades and normal ductal epithelia with and without cancer in the pancreas,” PLoS ONE, vol. 10, no. 2, Article ID e0117575, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. W.-Z. Wang, Q.-H. Pu, X.-H. Lin et al., “Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway,” Leukemia Research, vol. 39, no. 10, pp. 1117–1124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. Y.-T. Zheng, H.-Y. Yang, T. Li et al., “Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway,” Acta Pharmacologica Sinica, vol. 36, no. 5, pp. 614–626, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Walsh, A. Larkin, N. Swan et al., “RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation,” Cancer Letters, vol. 306, no. 2, pp. 180–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. I. Chang, X. You, G. Kong et al., “Loss of Dnmt3a and endogenous Kras(G12D+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis,” Leukemia, vol. 29, pp. 1847–1856, 2015. View at Google Scholar
  69. C. Oancea, B. Rüster, B. Brill et al., “STAT activation status differentiates leukemogenic from nonleukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML,” Genes and Cancer, vol. 5, no. 11-12, pp. 378–392, 2014. View at Google Scholar · View at Scopus
  70. M. A. Macha, S. Rachagani, S. Gupta et al., “Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling,” Cancer Letters, vol. 341, no. 2, pp. 166–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Bian, Y. Yu, S. Wang, and L. Li, “Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer,” Biochemical and Biophysical Research Communications, vol. 463, no. 4, pp. 612–617, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Liu, D. Xu, Q. Wang, D. Zheng, X. Jiang, and L. Xu, “LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4,” Digestive Diseases and Sciences, vol. 59, no. 7, pp. 1452–1460, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. D. C. Morran, J. M. Wu, N. B. Jamieson et al., “Targeting mTOR dependency in pancreatic cancer,” Gut, vol. 63, no. 9, pp. 1481–1489, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Nair, S. Sreevalsan, R. Basha et al., “Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors,” The Journal of Biological Chemistry, vol. 289, no. 40, pp. 27692–27701, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Wei, Y. Zhang, L. Geng, P. Zhang, G. Wang, and Y. Liu, “mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 3267–3282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Wang, H. Li, X.-G. Yan et al., “Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells,” Drug Design, Development and Therapy, vol. 9, pp. 575–601, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Guo, Y. Wang, W.-Y. Shi, B. Liu, S.-Q. Hou, and L. Liu, “MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway,” Molecules, vol. 17, no. 12, pp. 14733–14747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Fiorini, M. Menegazzi, C. Padroni et al., “Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis,” Apoptosis, vol. 18, no. 3, pp. 337–346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Wei, Y. D. Zhang, L. Geng, P. Zhang, G. Y. Wang, and Y. Liu, “mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 3267–3282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Taniuchi, M. Furihata, K. Hanazaki et al., “Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity,” Pancreas, vol. 44, no. 2, pp. 331–340, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Subramani, R. Lopez-Valdez, A. Arumugam, S. Nandy, T. Boopalan, and R. Lakshmanaswamy, “Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis,” PLoS ONE, vol. 9, no. 5, Article ID e97016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Androutsopoulos, G. Adonakis, A. Liava, P. Ravazoula, and G. Decavalas, “Expression and potential role of ErbB receptors in type II endometrial cancer,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 168, no. 2, pp. 204–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Grimont, A. V. Pinho, M. J. Cowley et al., “SOX9 regulates ERBB signalling in pancreatic cancer development,” Gut, vol. 64, no. 11, pp. 1790–1799, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. F. C. Bronfman, O. M. Lazo, C. Flores, and C. A. Escudero, “Spatiotemporal intracellular dynamics of neurotrophin and its receptors. Implications for neurotrophin signaling and neuronal function,” in Neurotrophic Factors, vol. 220 of Handbook of Experimental Pharmacology, pp. 33–65, 2014. View at Publisher · View at Google Scholar
  85. P. A. Forsyth, N. Krishna, S. Lawn et al., “p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells,” Journal of Biological Chemistry, vol. 289, no. 12, pp. 8067–8085, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Lawn, N. Krishna, A. Pisklakova et al., “Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells,” The Journal of Biological Chemistry, vol. 290, no. 6, pp. 3814–3824, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Esposito, E. Capoccia, F. Turco et al., “Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation,” Gut, vol. 63, no. 8, pp. 1300–1312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. S. J. Miknyoczki, A. J. P. Klein-Szanto, and B. A. Ruggeri, “Neurotrophin-Trk receptor interactions in neoplasia: a possible role in interstitial and perineural invasion in ductal pancreatic cancer,” Critical Reviews in Oncogenesis, vol. 7, no. 1-2, pp. 89–100, 1996. View at Publisher · View at Google Scholar · View at Scopus
  89. P. L. Che, Y. F. Yang, X. S. Han et al., “S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase,” Scientific Reports, vol. 5, article 8453, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. A. B. Frey, “Suppression of T cell responses in the tumor microenvironment,” Vaccine, vol. 33, no. 51, pp. 7393–7400, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. D. S. Shin and A. Ribas, “The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?” Current Opinion in Immunology, vol. 33, pp. 23–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. J. A. Wallace, F. Li, G. Leone, and M. C. Ostrowski, “Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution,” Cancer Research, vol. 71, no. 4, pp. 1203–1207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. R. A. Weinberg, “Coevolution in the tumor microenvironment,” Nature Genetics, vol. 40, no. 5, pp. 494–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. J.-H. Xu, J.-J. Fu, X.-L. Wang, J.-Y. Zhu, X.-H. Ye, and S.-D. Chen, “Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies,” World Journal of Gastroenterology, vol. 19, no. 26, pp. 4234–4241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Kabir, “Comment on: risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in korea: A Case-Control Study,” Journal of Korean Medical Science, vol. 28, no. 7, pp. 1114–1115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. S. J. Miknyoczki, W. Wan, H. Chang et al., “The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice,” Clinical Cancer Research, vol. 8, no. 6, pp. 1924–1931, 2002. View at Google Scholar · View at Scopus
  97. J. Guillermet-Guibert, L. Davenne, D. Pchejetski et al., “Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug,” Molecular Cancer Therapeutics, vol. 8, no. 4, pp. 809–820, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Gillespie, J. F. Dye, M. Schachter, and P. J. Guillou, “Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors,” British Journal of Cancer, vol. 68, no. 6, pp. 1122–1126, 1993. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Goel, J. Huang, and L. Klampfer, “K-Ras, Intestinal homeostasis and colon cancer,” Current Clinical Pharmacology, vol. 10, no. 1, pp. 73–81, 2015. View at Publisher · View at Google Scholar · View at Scopus